JZUS - Journal of Zhejiang University SCIENCE

Journal of Zhejiang University SCIENCE B

Accepted manuscript available online (unedited version)

Association of matrix metalloproteinase-9 C1562T polymorphism and coronary artery disease: a meta-analysis

Author(s): Xiao Wang¹, Lei-zhi Shi^1;2
Affiliation(s): 1. Department of Emergency, Zhejiang Hospital, Hangzhou 310013, China;2. Department of Thoracic Minimally Invasive Surgery, Linyi People's Hospital, Linyi 276000, China
Corresponding email(s): shileizhi@163.com
Key Words: Coronary artery disease, Matrix metalloproteinase-9, Polymorphism, Meta-analysis

Share this article to： More <<< Previous Paper \|Next Paper >>>

Xiao Wang, Lei-zhi Shi. Association of matrix metalloproteinase-9 C1562T polymorphism and coronary artery disease: a meta-analysis[J]. Journal of Zhejiang University Science B,in press.Frontiers of Information Technology & Electronic Engineering,in press.https://doi.org/10.1631/jzus.B1300088

@article{title="Association of matrix metalloproteinase-9 C1562T polymorphism and coronary artery disease: a meta-analysis",
author="Xiao Wang, Lei-zhi Shi",
journal="Journal of Zhejiang University Science B",
year="in press",
publisher="Zhejiang University Press & Springer",
doi="https://doi.org/10.1631/jzus.B1300088"
}

%0 Journal Article
%T Association of matrix metalloproteinase-9 C1562T polymorphism and coronary artery disease: a meta-analysis
%A Xiao Wang
%A Lei-zhi Shi
%J Journal of Zhejiang University SCIENCE B
%P 256-263
%@ 1673-1581
%D in press
%I Zhejiang University Press & Springer
doi="https://doi.org/10.1631/jzus.B1300088"

TY - JOUR
T1 - Association of matrix metalloproteinase-9 C1562T polymorphism and coronary artery disease: a meta-analysis
A1 - Xiao Wang
A1 - Lei-zhi Shi
J0 - Journal of Zhejiang University Science B
SP - 256
EP - 263
%@ 1673-1581
Y1 - in press
PB - Zhejiang University Press & Springer
ER -
doi="https://doi.org/10.1631/jzus.B1300088"

Abstract
Chinese Summary
Academic Network
Reviewer Comment

Abstract: Objective: Many investigations have studied the associations between matrix metalloproteinase-9 (MMP-9) C1562T polymorphisms and coronary artery disease (CAD). However, the conclusions of these studies were inconsistent. Therefore, this study was aimed at clarifying the association between MMP-9 C1562T polymorphisms and CAD in a large-scale meta-analysis. Methods: The PubMed and Embase databases were retrieved to collect all publications on the association between MMP-9 C1562T polymorphisms and CAD. Then the odd ratios (ORs) and 95% confidence intervals (95% CIs) for C1562T TT+TC versus CC genotype between CAD and the control groups were evaluated. Subgroup analysis was also performed according to different races. The meta-analysis was performed by Stata 10.0. Results: Sixteen case-control studies were included in our meta-analysis, involving 11 032 CAD patients and 4628 non-CAD controls. Compared with C allele carriers, East Asian T allele carriers TT+TC had a significantly higher risk of CAD (OR=1.43; 95% CI: 1.03–1.99; P=0.031); however, there were no significant associations in Western populations (OR=1.06; 95% CI: 0.96–1.18; P=0.240) or West Asians (OR=1.13; 95% CI: 0.75–1.70; P=0.565). When further analyzing the association between C1562T polymorphisms and myocardial infarction (MI, the most serious type of CAD), the risk of TT+TC genotype versus CC genotype for MI was significantly higher for the overall (OR=1.21; 95% CI: 1.04–1.40; P=0.012) and for East Asians (OR=1.58; 95% CI: 1.26–1.97; P=0.000) but not in Western populations (OR=1.12; 95% CI: 0.99–1.26; P=0.078). Conclusions: Our meta-analysis suggested an obvious ethnic difference in the association between MMP-9 C1562T polymorphisms and CAD. MMP-9 C1562T polymorphism was significantly related to CAD in East Asians. However, no significant associations were observed in either West Asians or Western populations.

基质金属蛋白酶-9 C1562T基因多态性与冠心病关系的meta分析

研究目的：探讨基质金属蛋白酶-9（MMP-9）C1562T基因多态性与冠心病之间的关系。
创新要点：通过综合分析，明确了MMP-9 C1562T基因多态性与冠心病的发生存在种族差异性，解决了以往单个研究由于样本量偏少而得出不同结论的弊端。
研究方法：利用meta分析可以扩大样本量的优势，分析了MMP-9 C1562T基因多态性与冠心病间的关系，且研究结论更为可靠。
重要结论：MMP-9 C1562T基因多态性与冠心病的发生存在显著的种族差异性：在东亚人群中，MMP-9 C1562T基因多态性与冠心病的发生密切相关；在西方人群及西亚人群中，MMP-9 C1562T基因多态性与冠心病的发生无显著相关性。

关键词组：冠心病；基质金属蛋白酶-9；基因多态性；Meta分析

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

References

[1] Alp,E, Menevse,S, Tulmac,M, 2009, Lack of association between matrix metalloproteinase-9 and endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in Turkish population DNA Cell Biol, 28(7):343-350.

[2] Asselbergs,F.W, Reynolds,W.F, Cohen-Tervaert,J.W, 2004, Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease Am J Med, 116(6):429-430.

[3] Blankenberg,S, Rupprecht,H.J, Poirier,O, 2003, Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease Circulation, 107(12):1579-1585.

[4] Brown,D.L, Hibbs,M.S, Kearney,M, 1995, Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina Circulation, 91(8):2125-2131.

[5] Cho,H.J, Chae,I.H, Park,K.W, 2002, Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention J Hum Genet, 47(2):88-91.

[6] Demacq,C, de Souza,A.P, Machado,A.A, 2006, Genetic polymorphism of matrix metalloproteinase (MMP)-9 does not affect plasma MMP-9 activity in healthy subjects Clin Chim Acta, 365(1-2):183-187.

[7] Demacq,C, Vasconcellos,V.B, Marcaccini,A.M, 2008, Functional polymorphisms in the promoter of the matrix metalloproteinase-9 (MMP-9) gene are not linked with significant plasma MMP-9 variations in healthy subjects Clin Chem Lab Med, 46(1):57-63.

[8] Fallah,S, Seifi,M, Ghasemi,A, 2010, Matrix metalloproteinase-9 and paraoxonase 1 Q/R192 gene polymorphisms and the risk of coronary artery stenosis in Iranian subjects J Clin Lab Anal, 24(5):305-310.

[9] Galis,Z.S, Sukhova,G.K, Lark,M.W, 1994, Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques J Clin Invest, 94(6):2493-2503.

[10] Ghaderian,S.M, Akbarzadeh Najar,R, Tabatabaei Panah,A.S, 2010, Genetic polymorphisms and plasma levels of matrix metalloproteinases and their relationships with developing acute myocardial infarction Coron Artery Dis, 21(6):330-335.

[11] Haberbosch,W, Gardemann,A, 2005, Gelatinase B CT polymorphism in relation to ischaemic heart disease Scand J Clin Lab Invest, 65(6):513-522.

[12] Horne,B.D, Camp,N.J, Carlquist,J.F, 2007, Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease Am Heart J, 154(4):751-758.

[13] Izidoro-Toledo,T.C, Guimaraes,D.A, Belo,V.A, 2011, Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells Naunyn-Schmiedebergs Arch Pharmacol, 383(6):547-554.

[14] Jefferis,B.J, Whincup,P, Welsh,P, 2010, Prospective study of matrix metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women Atherosclerosis, 208(2):557-563.

[15] Johnson,C, Galis,Z.S, 2004, Matrix metalloproteinase-2 and -9 differentially regulate smooth muscle cell migration and cell-mediated collagen organization Arterioscler Thromb Vasc Biol, 24(1):54-60.

[16] Kai,H, Ikeda,H, Yasukawa,H, 1998, Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes J Am Coll Cardiol, 32(2):368-372.

[17] Kim,J.S, Park,H.Y, Kwon,J.H, 2002, The roles of stromelysin-1 and the gelatinase B gene polymorphism in stable angina Yonsei Med J, 43(4):473-481.

[18] Koh,Y.S, Chang,K, Kim,P.J, 2008, A close relationship between functional polymorphism in the promoter region of matrix metalloproteinase-9 and acute myocardial infarction Int J Cardiol, 127(3):430-432.

[19] Lacchini,R, Metzger,I.F, Luizon,M, 2010, Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence DNA Cell Biol, 29(11):649-655.

[20] Loftus,I.M, Naylor,A.R, Goodall,S, 2000, Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption Stroke, 31(1):40-47.

[21] Lopez,A.D, Mathers,C.D, Ezzati,M, 2006, Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data Lancet, 367(9524):1747-1757.

[22] Marenberg,M.E, Risch,N, Berkman,L.F, 1994, Genetic susceptibility to death from coronary heart disease in a study of twins N Engl J Med, 330(15):1041-1046.

[23] Metzger,I.F, Luizon,M.R, Lacchini,R, 2012, Genetic variants in matrix metalloproteinase-9 gene modify metalloproteinase-9 levels in black subjects DNA Cell Biol, 31(4):504-510.

[24] Morgan,A.R, Zhang,B, Tapper,W, 2003, Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease J Mol Med (Berl), 81(5):321-326.

[25] Nanni,S, Melandri,G, Hanemaaijer,R, 2007, Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms Transl Res, 149(3):137-144.

[26] Newby,A.C, 2005, Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture Physiol Rev, 85(1):1-31.

[27] Nuzzo,D, Vasto,S, Balistreri,C.R, 2006, Role of proinflammatory alleles in longevity and atherosclerosis: results of studies performed on 1562C/T MMP-9 in centenarians and myocardial infarction patients from sicily Ann N Y Acad Sci, 1089(1):496-501.

[28] Opstad,T.B, Pettersen,A.A, Weiss,T.W, 2012, Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease Clin Chim Acta, 413(1-2):113-120.

[29] Pasterkamp,G, Schoneveld,A.H, Hijnen,D.J, 2000, Atherosclerotic arterial remodeling and the localization of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery Atherosclerosis, 150(2):245-253.

[30] Pollanen,P.J, Karhunen,P.J, Mikkelsson,J, 2001, Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study Arterioscler Thromb Vasc Biol, 21(9):1446-1450.

[31] Souza-Costa,D.C, Sandrim,V.C, Lopes,L.F, 2007, Anti-inflammatory effects of atorvastatin: modulation by the T786C polymorphism in the endothelial nitric oxide synthase gene Atherosclerosis, 193(2):438-444.

[32] Tayebjee,M.H, Lip,G.Y, Tan,K.T, 2005, Plasma matrix metalloproteinase-9, tissue inhibitor of metallo-proteinase-2, and CD40 ligand levels in patients with stable coronary artery disease Am J Cardiol, 96(3):339-345.

[33] Wang,J, Warzecha,D, Wilcken,D, 2001, Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis Clin Sci (Lond), 101(1):87-92.

[34] Wang,L, Ma,Y.T, Xie,X, 2012, Interaction between MMP-9 gene polymorphisms and smoking in relation to myocardial infarction in a Uighur population Clin Appl Thromb Hemost, 18(1):72-78.

[35] Welsh,P, Whincup,P.H, Papacosta,O, 2008, Serum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle-aged men QJM, 101(10):785-791.

[36] Zhang,B, Ye,S, Herrmann,S.M, 1999, Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis Circulation, 99(14):1788-1794.

[37] Zhang,B, Henney,A, Eriksson,P, 1999, Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1 Hum Genet, 105(5):418-423.

[38] Zhi,H, Wang,H, Ren,L, 2010, Functional polymorphisms of matrix metallopeptidase-9 and risk of coronary artery disease in a Chinese population Mol Biol Rep, 37(1):13-20.

- Go to

基质金属蛋白酶-9 C1562T基因多态性与冠心病关系的meta分析

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

References